Yanshan Petrochemical's three new EVA products help increase efficiency
Time of Update: 2022-08-27
From February to March, the second high-pressure unit of Yanshan Petrochemical Synthetic Resin Plant has continuously produced EVA products for 44 days, with an output of 20,793 ton, created the longest running time record of co-production EVA, and successively successfully developed and produced new products such as photovoltaic materials, isolation cabin upgraded products and pre-coating films.
Gao Fu, Eric Rubin, Fu Yangxin, Chen Xiaowei, Li Bin, etc.: Develop a new generation of high-efficiency Covid-19 vaccines and drugs to end the new crown epidemic
Time of Update: 2022-06-14
These experts include: Professor Eric Rubin, Editor-in-Chief of the New England Journal of Medicine (NEJM), Professor Xiao Ruiping, Associate Editor of NEJM and Executive Editor of NEJM Frontiers in Medicine, Professor Gao Fu of the Chinese Center for Disease Control and Prevention, Institute of Microbiology, Chinese Academy of Sciences, Shanghai Jiaotong University School of Medicine Prof.
Vembrolizumab: A 'first in class' ADC to challenge first-line lymphoma treatment
Time of Update: 2022-05-02
At the 2021 American Society of Hematology (ASH) annual meeting, vebotuzumab combined with R-CHP (rituximab, cyclophosphamide, doxorubicin, prednisone) versus R-CHOP (rituximab) The phase III POLARIX study of monoclonal antibody, cyclophosphamide, doxorubicin, vincristine, prednisone) in the first-line treatment of DLBCL has released detailed data and published it simultaneously in the New England Journal of Medicine .
Under the implementation of the new version of the Pharmacopoeia, microbiological testing equipment in the subdivision of pharmaceutical equipment is promising
Time of Update: 2021-12-29
The 2021 semi-annual report of Tailin Biology shows that the company's main business is the research and development, manufacturing and sales of pharmaceutical equipment such as microbial detection and control technology system products and organic matter analysis instruments .
Diet is more beneficial to metabolic health and anti-aging
Time of Update: 2021-12-02
This research builds on the team’s pioneering work in mice and humans, demonstrating that diet and specific combinations of protein, fat, and carbohydrate are effective for aging, obesity, heart disease, immune dysfunction, and metabolic diseases ( Such as type 2 diabetes, etc.
CDE Announcement on Issuing the "Technical Guidelines for Clinical Trials of Generic Drugs for Oral Inhalation Drugs that have been Marketed Abroad and Domestically Unmarketed
Time of Update: 2021-12-01
45 of 2021) Release Date: 20211119 In order to further guide the scientific and reasonable development of generic drugs for oral inhalation preparations, under the deployment of the National Medical Products Administration, the Center for Drug Evaluation organized the formulation of the "Guidelines for the Clinical Trial of Generic Drugs for Oral Inhalation Preparations (Trial Implementation) )" (see attachment) .
Synthetic phenol for industrial use (1
Time of Update: 2021-11-24
11 (according to 1997 international relative atomic mass)2 Reference standardsThe provisions contained in the following standards constitute the provisions of this standard through quotation in this standard .
3. 2 Synthetic phenol for industrial use should meet the technical requirements shown in Table 1 .
MicroRNA noise reduction mechanism and accurate tumor cell recognition
Time of Update: 2021-09-13
Recently, based on the research idea of "digital-carbon-based fusion", Wang Xiaowo's research group from the Department of Automation of Tsinghua University revealed the gene expression noise reduction mechanism of microRNA and applied it to synthetic gene circuits Design, by guiding the construction of an artificial gene cell classifier, the precise identification of tumor cells has been achieved .
Synthesis of the metal anticancer ru-rhein in tumor tissue
Time of Update: 2021-02-24
recently published in the National Science Review, In the NSR article, researchers at Nanjing Normal University and Nanjing University used the "bio orthosis catalytic lethality" strategy to develop a highly active tumor-targeted metal drug, Ru-rhein, a copper species with high concentrations in tumor tissue that can act as a catalyst to turn non-toxic premeditations Ru-N and rhein-alkyne into cytotoxic Ru-rhein, Ru-rhein-targeted tumor mitochondrials, and induced autophagy.
The fourth batch of 158 products to be selected: injection price reduction hit
Time of Update: 2021-02-11
Pharmaceutical Network February 4th, February 3rd, the fourth batch of national drug centralized volume procurement in Shanghai officially opened the bid, 45 varieties of 8 injection varieties, 3 eye
CDE: Guidelines for clinical pharmacological research on antibody drugs in the new coronavirus are published
Time of Update: 2020-11-14
In accordance with the requirements of the Notice of the General Division of the State Drug Administration on the Procedure for the Issue of Technical Guidelines for the Issue of Drugs (Pharmaceutical Supervision and Administration No. 9 of 2020), it shall be issued with the approval of the State Drug Administration and shall come into effect as of the date of publication.
A large number of OTC drugs, health insurance is not reimbursed
Time of Update: 2020-10-24
Referment makes it clear that over-the-counter drugs already in the National List of Essential Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drugs (the "Medicare Drug Catalog") may continue to be retained as eligible and, like other medicines, managed in accordance with the current medical insurance policy.
"Annual Report" Lu Anti-Pharma's net profit last year was 10.86 million Year-on-Year Profit
Time of Update: 2020-06-30
On April 18, , Lu Anti-Pharma (600789) disclosed its annual report that its net profit for 2013 was RMB10,857.9 million, a year-on-year profit of RMB0.02 per share In 2012, Lu anti-pharma lost 134 mil
Real world evidence cases to improve the efficiency of clinical trials
Time of Update: 2019-12-06
Although randomization may always be the gold standard, this real-world use case helps to improve the efficiency of clinical trials and reduce costs Clinical trials often involve a large number of sub
Sichuan issues the 13th five year plan of action to curb and prevent AIDS
Time of Update: 2017-06-03
[policies and regulations of China Pharmaceutical network] recently, Sichuan Province issued the 13th five year plan of action to curb and prevent AIDS in Sichuan Province, highlighting key areas, key